[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 14, Number 4 (Winter 2016) ::
jjums 2016, 14(4): 8-15 Back to browse issues page
Evaluation of Carbapenemase resistance in Pseudomonas aeruginosa and Enterobacteriaceae family isolated from clinical specimens by using phenotypic methods in 2014-2015
tahmineh ebrahimzadeh shiraz , hadi rezaei yazdi, mahdi alijanianzadeh
msc student
Abstract:   (607 Views)

Introduction: Carbapenems are drugs with an extended spectrum but There are some problems when Carbapenems resistance is increased. Pseudomonas aeruginosa is an important nosocomial pathogen but Imipenem resistance increases and it is on second line therapy of multidrug resistance Pseudomonas aeruginosa infections. The importance of Enterobacteriaceae family is due to the increasing number of patients, According to this bacterium family 30-40 percent of Septicemiais infected and 70 percent of urinary tract infections. Carbapenems are the last defense line in critical infections with these pathogens.

Materials and Methods: this study collected 196 isolated bacteria of Pseudomonas aeruginosa and Enterobacteriaceae family from Hospitals patient of Tehran and evaluates them by phenotypic and biochemical methods. also, The researcher studies the disk diffusion method and use it to determine antibiotic sensitivity of all bacteria according to the CLSI standard table.

Results: From the total of 196 bacteria collected, the resistance to Meropenem is %39.79 and Imipenem is %45.91 and 30.10 percent  to Meropenem and Imipenem resistance so that the percent resistance of bacteria is as follows: Pseudomonas aeruginosa resistance to Meropenem is %39.62 and Imipenem is %43.39. Meropenem and Imipenem resistance in Enterobacteriaceae family are as follows: Salmonella resistance to Imipenem and Meropenem is %0 and %50, Citrobacter koseri the resistance to Imipenem and Meropenem %0 and %50, Citrobacter freundii Meropenem resistance of %28.57 and Imipenem %28.57, Escherichia coli resistance to Meropenem %39.70 and Imipenem %47.05, Klebsiella oxytoca resistance to Meropenem %46.6 and %40 Imipenem and Meropenem resistance Klebsiella pneumoniae %34.14 and Imipenem %53.65, respectively.

Conclusion: There is an increasing resistance to Meropenem and Imipenem antibiotics in treatment of Pseudomonas aeruginosa and Enterobacteriaceae family in our country. Hence, it should be properly and reasonably use these antibiotics.

keywords: Carbapenem, Pseudomonas aeruginosa, Enterobacteriaceae family, phenotypic, Tehran

Keywords: Carbapenem, Pseudomonas aeruginosa, Enterobacteriaceae family, phenotypic, Tehran
Full-Text [PDF 291 kb]   (179 Downloads)    
Type of Study: Research | Subject: Microbshensi
Received: 2016/08/2 | Accepted: 2017/01/7 | Published: 2017/03/8
Send email to the article author

Add your comments about this article
Your username or email:

Write the security code in the box >



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

ebrahimzadeh shiraz T, rezaei yazdi H, alijanianzadeh M. Evaluation of Carbapenemase resistance in Pseudomonas aeruginosa and Enterobacteriaceae family isolated from clinical specimens by using phenotypic methods in 2014-2015. jjums. 2016; 14 (4) :8-15
URL: http://jmj.jums.ac.ir/article-1-863-en.html
Volume 14, Number 4 (Winter 2016) Back to browse issues page
فصلنامه دانشگاه علوم پزشکی جهرم Journal of Jahrom University of Medical Sciences
Persian site map - English site map - Created in 0.047 seconds with 787 queries by yektaweb 3443